Publications by authors named "Martin Eilers"

Claim this Profile
A
Accelerating Drug Development for Neuroblastoma: Consensus Statement From the Third Neuroblastoma Drug Development Strategy Forum.
Steven G DuBois, Lucas Moreno, John Anderson, Shahab Asgharzadeh, Ro Bagatell, Martin Eilers

Pediatr Blood Cancer· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncogenic YAP sensitizes cells to CHK1 inhibition via CDK4/6 driven G1 acceleration.
Dörthe Gertzmann, Cornelius Presek, Anna Lena Mattes, Marco Sänger, Marie Zoller, Martin Eilers

EMBO Rep· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The USP11/TCEAL1 complex promotes transcription elongation to sustain oncogenic gene expression in neuroblastoma.
Markus Dehmer, Katrin Trunk, Peter Gallant, Daniel Fleischhauer, Mareike Müller, Martin Eilers

Genes Dev· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maintenance of p-eIF2α levels by the eIF2B complex is vital for colorectal cancer.
Ivana Paskov Škapik, Chiara Giacomelli, Sarah Hahn, Hanna Deinlein, Peter Gallant, Martin Eilers

EMBO J· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Targeting Translation Initiation Bypasses Signaling Crosstalk Mechanisms That Maintain High MYC Levels in Colorectal Cancer.
Armin Wiegering, Friedrich W Uthe, Thomas Jamieson, Yvonne Ruoss, Melanie Hüttenrauch, Martin Eilers

Cancer Discov· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phenotypic screens identify SCAF1 as critical activator of RNAPII elongation and global transcription.
Pranjali Bhandare, Ashwin Narain, Julia Hofstetter, Teresa Rummel, Julia Wenzel, Ursula Eilers, Martin Eilers

Nucleic Acids Res· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retraction Note: Suppression of inflammation and acute lung injury by Miz1 via repression of C/EBP-δ.
Hanh Chi Do-Umehara, Cong Chen, Daniela Urich, Liang Zhou, Ju Qiu, Martin Eilers

Nat Immunol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting MYCN upregulates L1CAM tumor antigen in MYCN-dysregulated neuroblastoma to increase CAR T cell efficacy.
Laura Grunewald, Lena Andersch, Konstantin Helmsauer, Silke Schwiebert, Anika Klaus, Martin Eilers

Pharmacol Res· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: USP10 drives cancer stemness and enables super-competitor signalling in colorectal cancer.
Michaela Reissland, Oliver Hartmann, Saskia Tauch, Jeroen M Bugter, Cristian Prieto-Garcia, Martin Eilers

Oncogene· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
USP10 drives cancer stemness and enables super-competitor signalling in colorectal cancer.
Michaela Reissland, Oliver Hartmann, Saskia Tauch, Jeroen M Bugter, Cristian Prieto-Garcia, Martin Eilers

Oncogene· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune evasion: An imperative and consequence of MYC deregulation.
Bastian Krenz, Jongkuen Lee, Toshitha Kannan, Martin Eilers

Mol Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NEAT1 promotes genome stability via mA methylation-dependent regulation of CHD4.
Victoria Mamontova, Barbara Trifault, Anne-Sophie Gribling-Burrer, Patrick Bohn, Lea Boten, Martin Eilers

Genes Dev· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting MYC effector functions in pancreatic cancer by inhibiting the ATPase RUVBL1/2.
Markus Vogt, Nevenka Dudvarski Stankovic, Yiliam Cruz Garcia, Julia Hofstetter, Katharina Schneider, Martin Eilers

Gut· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association with TFIIIC limits MYCN localisation in hubs of active promoters and chromatin accumulation of non-phosphorylated RNA polymerase II.
Raphael Vidal, Eoin Leen, Steffi Herold, Mareike Müller, Daniel Fleischhauer, Martin Eilers

Elife· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The MYCN oncoprotein is an RNA-binding accessory factor of the nuclear exosome targeting complex.
Dimitrios Papadopoulos, Stefanie Anh Ha, Daniel Fleischhauer, Leonie Uhl, Timothy J Russell, Martin Eilers

Mol Cell· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulation of BCR-mediated Ca mobilization by MIZ1-TMBIM4 safeguards IgG1 GC B cell-positive selection.
Lingling Zhang, Amparo Toboso-Navasa, Arief Gunawan, Abdouramane Camara, Rinako Nakagawa, Martin Eilers

Sci Immunol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PAF1c links S-phase progression to immune evasion and MYC function in pancreatic carcinoma.
Abdallah Gaballa, Anneli Gebhardt-Wolf, Bastian Krenz, Greta Mattavelli, Mara John, Martin Eilers

Nat Commun· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Beyond gene expression: how MYC relieves transcription stress.
Dimitrios Papadopoulos, Leonie Uhl, Stefanie Anh Ha, Martin Eilers

Trends Cancer· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LRP8-mediated selenocysteine uptake is a targetable vulnerability in MYCN-amplified neuroblastoma.
Hamed Alborzinia, Zhiyi Chen, Umut Yildiz, Florencio Porto Freitas, Felix C E Vogel, Martin Eilers

EMBO Mol Med· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MYC determines lineage commitment in KRAS-driven primary liver cancer development.
Luana D'Artista, Athina Anastasia Moschopoulou, Iros Barozzi, Amanda J Craig, Marco Seehawer, Martin Eilers

J Hepatol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
USP28 controls SREBP2 and the mevalonate pathway to drive tumour growth in squamous cancer.
Carina R Maier, Oliver Hartmann, Cristian Prieto-Garcia, Kamal M Al-Shami, Lisa Schlicker, Martin Eilers

Cell Death Differ· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Crystal structure of a covalently linked Aurora-A-MYCN complex.
Mathias Diebold, Lars Schönemann, Martin Eilers, Christoph Sotriffer, Hermann Schindelin

Acta Crystallogr D Struct Biol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MYC multimers shield stalled replication forks from RNA polymerase.
Daniel Solvie, Apoorva Baluapuri, Leonie Uhl, Daniel Fleischhauer, Theresa Endres, Martin Eilers

Nature· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MYC promotes immune-suppression in triple-negative breast cancer via inhibition of interferon signaling.
Dario Zimmerli, Chiara S Brambillasca, Francien Talens, Jinhyuk Bhin, Renske Linstra, Martin Eilers

Nat Commun· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RNA polymerase I inhibition induces terminal differentiation, growth arrest, and vulnerability to senolytics in colorectal cancer cells.
Christoph Otto, Carolin Kastner, Stefanie Schmidt, Konstantin Uttinger, Apoorva Baluapuri, Martin Eilers

Mol Oncol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis